Valneva SE Pref. Stock Euronext Paris
Stocks
VLAP
FR0011472943
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Euronext Paris
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| Market Cap | 530M 614M 497M 454M 854M 58.59B 858M 5.9B 2.3B 29.63B 2.31B 2.26B 98.37B | P/E 2026 * |
-6.42x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 664M 769M 622M 568M 1.07B 73.36B 1.07B 7.39B 2.88B 37.1B 2.89B 2.82B 123B | EV / Sales 2026 * |
4.4x | EV / Sales 2027 * | 2.09x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Valneva SE Pref.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 2021-07-28 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2023-12-19 | |
James Sulat
BRD | Director/Board Member | 75 | 2013-03-06 |
| Chairman | 65 | 2023-12-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 615M | |
| -0.78% | -1.42% | +2.96% | +21.65% | 50.47B | |
| -6.00% | -0.75% | +447.48% | +535.14% | 44.56B | |
| -0.24% | +0.74% | +37.18% | +16.26% | 43.08B | |
| -1.55% | -2.07% | +19.83% | +71.70% | 41.7B | |
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | |
| -1.79% | -3.24% | +26.32% | +125.06% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.88% | -0.66% | +11.63% | +27.62% | 14.58B | |
| -1.66% | -1.25% | +78.49% | +42.97% | 13.92B | |
| Average | -1.38% | -1.06% | +80.42% | +111.08% | 30.51B | |
| Weighted average by Cap. | -1.70% | -1.06% | +96.28% | +129.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 151M 175M 142M 129M 243M 16.68B 244M 1.68B 655M 8.44B 657M 642M 28.01B | 283M 328M 266M 243M 456M 31.31B 458M 3.15B 1.23B 15.83B 1.23B 1.21B 52.57B |
| Net income | -81.11M -93.97M -76.04M -69.42M -131M -8.96B -131M -903M -352M -4.53B -353M -345M -15.05B | 53.07M 61.48M 49.75M 45.42M 85.48M 5.86B 85.86M 591M 230M 2.97B 231M 226M 9.85B |
| Net Debt | 134M 155M 125M 114M 215M 14.77B 216M 1.49B 580M 7.47B 581M 569M 24.81B | 62.48M 72.38M 58.57M 53.47M 101M 6.9B 101M 695M 271M 3.49B 272M 266M 11.59B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- VLAP Stock
Select your edition
All financial news and data tailored to specific country editions
